Pharmaceuticals Africa

Africa Halal Pharmaceuticals Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Africa Halal Pharmaceuticals Market Industry Trends and Forecast to 2034: Segmented by (Product, Certification, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Africa · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $1.39 Bn Placeholder estimate
Estimate 2025 $1.51 Bn 1.4% of the global market
Projected 2034 $3.15 Bn 108.4% Adds $1.64 Bn over 9 forecast years
CAGR 2025–2034 8.5% Faster than 37% of 180 Pharmaceuticals markets here
Key players 5
  • Africa is 1.39% of the global market.
  • Among regions, the largest is North America at $56.97 Bn.
  • Fastest growing: Africa (this report) at 8.5% a year.
  • Africa ranks 6th of 6 by size among regions.

Market size projection

Africa

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$1.64 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Halal Pharmaceuticals Market market size by year, Africa
YearMarket sizeChange that yearSince 2025
2024 (estimate) $1.39 Bn — —
2025 (base) $1.51 Bn +$118.4 Mn —
2026 (forecast) $1.64 Bn +$128.5 Mn +8.5%
2027 (forecast) $1.78 Bn +$139.4 Mn +17.7%
2028 (forecast) $1.93 Bn +$151.2 Mn +27.7%
2029 (forecast) $2.09 Bn +$164.1 Mn +38.6%
2030 (forecast) $2.27 Bn +$178.0 Mn +50.4%
2031 (forecast) $2.47 Bn +$193.1 Mn +63.1%
2032 (forecast) $2.68 Bn +$209.6 Mn +77%
2033 (forecast) $2.90 Bn +$227.4 Mn +92.1%
2034 (forecast) $3.15 Bn +$246.7 Mn +108.4%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $108.77 Bn
  2. North America $56.97 Bn
  3. US $39.81 Bn
  4. APAC $26.18 Bn
  5. Europe $19.36 Bn
  6. Canada $9.98 Bn
  7. China $7.85 Bn
  8. Japan $6.66 Bn
  9. Latin America $5.51 Bn
  10. Middle East $4.31 Bn
  11. Germany $3.44 Bn
  12. France $3.30 Bn
  13. Italy $3.00 Bn
  14. Brazil $3.01 Bn
  15. UK $2.66 Bn
  16. Ecuador $2.30 Bn
  17. Saudi Arabia $2.08 Bn
  18. India $2.02 Bn
  19. Spain $1.87 Bn
  20. Mexico $1.71 Bn
  21. Africa (this report) $1.51 Bn
  22. Australia $1.29 Bn
  23. Russia $1.16 Bn
  24. New Zealand $1.16 Bn
  25. South Africa $756.1 Mn
  26. UAE $493.2 Mn
  27. Egypt $352.3 Mn
  28. Philippines $259.3 Mn
  29. Hong Kong $183.0 Mn
  30. Malaysia $166.6 Mn
  31. Singapore $148.8 Mn
  32. Thailand $115.2 Mn
  33. Kenya $69.4 Mn

Report snapshot

Africa Halal Pharmaceuticals Market Analysis at a glance
Market size, 2025$1.51 Bn placeholder estimate
Forecast, 2034$3.15 Bn placeholder estimate
Growth (CAGR), 2025–20348.5% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, certification and end user (see all)
Key playersCCM Duopharma Biotech, Pharmaniaga, Bio Farma, Kalbe Farma, Hikma Pharmaceuticals PLC (see all)
Regulator in AfricaAMASource: African Union, African Medicines Agency treaty. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Africa Halal Pharmaceuticals Market Analysis Executive Summary

Halal pharmaceuticals are medicines made without ingredients or processes forbidden in Islam, certified for Muslim patients.

Key segments of the halal Pharmaceuticals market include product (Prescription Drugs, OTC Medicines and Vaccines) and certification (Halal-Certified and Seeking Certification).

Bar chart: Africa Halal Pharmaceuticals market size, 2024–2034, placeholder estimates. $1.39 Bn in 2024, $1.51 Bn in 2025 and $3.15 Bn in 2034, 8.5% CAGR.
Africa Halal Pharmaceuticals market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Africa Halal Pharmaceuticals Market Dynamics

Market Growth Drivers

Rising incomes, fast-growing private hospital chains, medical tourism, government health reforms and a young, digital-first population are driving the halal Pharmaceuticals market.

Opportunity

Public-private partnerships, digital health and growing middle classes in Asia, the Middle East, Africa and Latin America give the halal Pharmaceuticals market strong room to grow.

Market Restraints

Uneven quality standards, limited insurance coverage, high out-of-pocket costs and regulatory differences between countries hold back the halal Pharmaceuticals market.

Competitive Landscape for Halal Pharmaceuticals Market in Africa

The halal Pharmaceuticals market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Halal Pharmaceuticals Market in Africa

Halal Pharmaceuticals in Africa: rules and payment

The African Medicines Agency (AMA), set up by an African Union treaty in force since November 2021, aims to bring the work of national regulators together.⁠[1] In some of the countries we cover here, medicines are approved by EDA (Egypt)⁠[2], PPB (Kenya)⁠[3] and SAHPRA (South Africa)⁠[4]. How care is paid for in some of these countries: universal health insurance (Egypt)⁠[5], the SHA (Kenya)⁠[6] and planned National Health Insurance (South Africa)⁠[7].

[1] African Union, African Medicines Agency treaty. Checked 14 Nov 2026.

[2] Egyptian Drug Authority. Checked 14 Nov 2026.

[3] Pharmacy and Poisons Board. Checked 14 Nov 2026.

[4] South African Health Products Regulatory Authority. Checked 14 Nov 2026.

[5] Universal Health Insurance Authority. Checked 14 Nov 2026.

[6] Social Health Authority. Checked 14 Nov 2026.

[7] National Department of Health. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for halal Pharmaceuticals. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Africa.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Halal Pharmaceuticals right now, from free public sources.

Latest research 6 papers since 2021 (worldwide)

  1. A simple and cost-effective detection of capsule origin source using FTIR-ATR. Journal of food science and technology, 2025
  2. Beyond Side Effect: Immuno-Ethical Risk Analysis of Animal-Derived Ingredients in Pharmaceuticals. Risk management and healthcare policy, 2026
  3. Understanding Halal pharmaceuticals: Views from outpatients in a Malaysian state hospital. The Medical journal of Malaysia, 2024
  4. Towards halal pharmaceutical: Exploring alternatives to animal-based ingredients. Heliyon, 2023
  5. Knowledge, Perceptions and Attitudes among Sharia Practitioners in Palestine Regarding Halal Pharmaceuticals: An Exploratory Study. Journal of religion and health, 2022
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Halal Pharmaceuticals in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Halal Pharmaceuticals market in Africa?
Placeholder estimate: about $1.51 Bn in 2025, rising to about $3.15 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Halal Pharmaceuticals market in Africa growing?
Placeholder estimate: about 8.5% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Halal Pharmaceuticals market report cover?
The report splits the market by product (Prescription Drugs, OTC Medicines, Vaccines, Supplements), certification (Halal-Certified, Seeking Certification) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Halal Pharmaceuticals market?
Key players include CCM Duopharma Biotech, Pharmaniaga, Bio Farma, Kalbe Farma and Hikma Pharmaceuticals PLC.
What is driving the Halal Pharmaceuticals market?
Rising incomes, fast-growing private hospital chains, medical tourism, government health reforms and a young, digital-first population are driving the halal Pharmaceuticals market.
Who regulates Halal Pharmaceuticals in Africa?
The African Medicines Agency (AMA), set up by an African Union treaty in force since November 2021, aims to bring the work of national regulators together. Source: African Union, African Medicines Agency treaty. Checked 14 Nov 2026.
How much research is published on Halal Pharmaceuticals?
PubMed lists 6 papers on Halal Pharmaceuticals added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Halal Pharmaceuticals in Africa? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in Africa

See all
Same topic, other categories

Related on pharmacy and generics

See the topic